(Press-News.org) There is a wealth of published information describing interactions between drugs used to treat cardiovascular disease and the genetic variations that can affect how patients respond to them. But few heart specialists make routine use of this potentially life-saving data.
To help physicians make better-informed clinical decisions, researchers from the University of Chicago and Stanford University combed through scientific literature on the pharmacogenomics of 71 leading cardiovascular drugs and compiled summaries, published in the June issue of the Mayo Clinic Proceedings.
"Tens of thousands of patients have been studied and the connections between common medications and the genetic variants that can lead to adverse drug reactions or treatment non-response have been described, but few physicians track this information or even know where to find it," said study author Peter H. O'Donnell, MD, assistant professor of medicine at the University of Chicago.
"One dose does not fit all," he said. "So we set out to boost awareness and simplify access. We assessed the quantity and quality of the literature, ranked the most relevant studies for clinicians and condensed the data into a series of prescribing decision aids."
Cardiovascular drugs are a common cause of the estimated two million adverse drug reactions that occur each year in the United States. More than 50,000 patients are treated in emergency rooms annually for bad reactions to cardiovascular drugs. Patients over age 65 are particularly at risk, especially those taking warfarin and anti-platelet agents.
Although adverse drug outcomes occur in specific patients, medications are studied and approved based on large, carefully selected populations, the authors note. Performance in that setting "is less informative when treating individual patients, who show remarkable variability in their response to medications."
So the researchers probed every paper published in English between January 2011 and May 2013, searching for articles that described a link between genetic variations and an unanticipated pharmacological or clinical outcome caused by a cardiovascular drug.
They found 597 unique publications, involving 611 genetic markers or "variants" and 884 drug-variant pairs. Fifty-one of the 71 cardiovascular drugs they focused on (71.8 percent) had detectable pharmacogenomic effects.
Of the 884 drug-variant pairs, 92 interactions involving 23 different drugs warranted summarization for consideration during clinical decision making. Four high-scoring drug-variant pairs--involving the drugs clopidogrel (Plavix®), metoprolol (Lopressor®), simvastatin (Zocor®) and warfarin (Coumadin® and others)--deserved particular attention.
The researchers also devoted extra attention to the nine most common cardiovascular drugs--such as simvastatin, which is prescribed 96.8 million times a year. They found that seven of these frequently prescribed medications warranted pharmacogenomic guidelines for clinical consideration. For the simvastatin example, roughly one to two percent of patients who take the ubiquitous drug develop myopathy, a painful muscle injury that can lead to kidney complications and death in its most severe forms.
"Our findings are already making a difference in patient care," said co-author, cardiologist Matthew Sorrentino, MD, professor of medicine at the University of Chicago. "I have long been familiar with the common variations in response to drugs, but, like most physicians in my specialty, I had limited knowledge of the pharmacogenomics behind it, or the ability of this information to predict a problem."
"As we worked on this project, one of my patients developed chest pain caused by acid reflux. The standard drug for that situation didn't help," he said. "From his genetics we learned that he would probably respond better to another agent, so we changed his medication. His reflux--and his chest pain--promptly went away. Easy access to this information helped us make the change quickly, in days instead of weeks."
The problem, he added, is that "there is no one place where all this information is available, no fast, easy way to find it."
One recent survey, published in July 2014, confirmed that among physicians "familiarity with pharmacogenomics continues to be low and that knowledge gaps persist." The study reported just 12.6 percent of physicians were extremely or very familiar with pharmacogenomics. The authors cite other surveys. In one, only 10 percent of respondents felt they were adequately informed about the applicability of genetic testing to drug therapy. Another found that only 13 percent of respondents felt well informed about the role of pharmacogenomics in therapeutic decision making.
"There is substantial pharmacogenetic information on cardiovascular drugs that could potentially be applied to patient care," O'Donnell and colleagues conclude. "Considering the hundreds of millions of annual cardiovascular drug prescriptions, the frequency of adverse drug reactions, and the variable levels of drug response, the impact of this knowledge is potentially prodigious."
INFORMATION:
The National Institutes of Health, the Conquer Cancer Foundation (ASCO) and the William F. O'Connor Foundation funded the study. Additional authors include first-author Amy L. Kaufman, Jared Spitz, Michael Jacobs, Shennin Yuen, Keith Danahey, Donald Saner and Mark J. Ratain, from the University of Chicago; and Teri E. Klein and Russ B. Altman from Stanford University. Three of the authors, including O'Donnell, are co-inventors of a pending patent for the Genomic Prescribing SystemTM.
Academic programs that provide alternatives to traditional remedial education help students succeed at community colleges, but different programs result in a range of outcomes for various sub-populations of students. Drew Allen, a New York University doctoral student and director of the Office of Research, Evaluation, and Program Support at the City University of New York (CUNY), devoted his doctoral research to the evaluation of three current programmatic approaches at CUNY community colleges.
Entering community college students are often required to take remedial, ...
Some female members of a critically endangered species of sawfish are reproducing in the wild without sex. The discovery, reported in the Cell Press journal Current Biology on June 1, marks the first time living offspring from "virgin births" have been found in a normally sexually reproducing vertebrate in the wild, the researchers say.
Earlier evidence that vertebrates might sometimes reproduce via a process called parthenogenesis had primarily come from isolated examples of captive animals--including birds, reptiles, and sharks. In those instances, the animals in question ...
Despite guideline recommendations to limit medical tests before low-risk surgeries, electrocardiograms (ECGs) and chest x-rays are still performed frequently, found a study in CMAJ (Canadian Medical Association Journal).
Evidence indicates that for patients undergoing low-risk surgery, routine testing does not improve outcomes and can actually lead to surgical delays, patient anxiety and other issues. The Choosing Wisely campaign, which started in the United States and spread to Canada and other countries, aims to raise awareness of unnecessary tests and procedures among ...
Radon gas is a silent health threat, and Canada needs to align its guidelines for acceptable radon levels with World Health Organization (WHO) limits, argues an editorial in CMAJ (Canadian Medical Association Journal).
"We are left in an odd situation in Canada," writes Dr. Diane Kelsall, Deputy Editor, CMAJ. "Drivers and passengers are required to wear seat belts, which are estimated to save about 1000 lives per year. Smoke alarms are required in most jurisdictions, reducing the annual rate of fire-related deaths from 130 per million households by about two-thirds. Yet, ...
ROSEMONT, Ill.--Woman in general have a higher incidence of osteoporosis-related hip fractures yet, conversely, they have a lower rate of mortality than men with the same fracture, according to a study in the June 2015 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS). In addition, doctors don't always recognize or treat osteoporosis in men as often as they do in women.
"Male and Female Differences Matter in Musculoskeletal Disease" details the differences between how common musculoskeletal disorders manifest themselves in males versus females. ...
ROCHESTER, Minn. -- Why are major surgical errors called "never events?" Because they shouldn't happen -- but do. Mayo Clinic researchers identified 69 never events among 1.5 million invasive procedures performed over five years and detailed why each occurred. Using a system created to investigate military plane crashes, they coded the human behaviors involved to identify any environmental, organizational, job and individual characteristics that led to the never events. Their discovery: 628 human factors contributed to the errors overall, roughly four to nine per event. ...
New research on kidney stone formation reveals that zinc levels may contribute to kidney stone formation, a common urinary condition that can cause excruciating pain. The research found that zinc may be the core by which stone formation starts.
The study, led by UC San Francisco, opens a new perspective into the cause of urinary stones and related diseases and might ultimately lead to the identification of new preventive and therapeutic approaches.
The article appears in the scientific journal PLOS ONE.
"The ultimate goal of our research team is to prevent kidney ...
TORONTO, ON [1 June 2015] - By observing galaxies billions of light-years away, a team of astronomers has detected tube-like structures mere hundreds of kilometres above the Earth's surface.
"For over 60 years, scientists believed these structures existed but by imaging them for the first time, we've provided visual evidence that they are really there," said Cleo Loi of the ARC Centre of Excellence for All-sky Astrophysics (CAASTRO) at the University of Sydney and lead author of a paper published in Geophysical Research Letters last week.
The astronomers--including ...
Breastfeeding for six months or longer was associated with a lower risk of childhood leukemia compared with children who were never breastfed or who were breastfed for a shorter time, according to an article published online by JAMA Pediatrics.
Leukemia is the most common childhood cancer and accounts for about 30 percent of all childhood cancers. Still, little is known about its cause. Breast milk is meant to exclusively supply all the nutritional needs of infants and current recommendations include exclusively breastfeeding for the first six months of life to optimize ...
A study of patients in Denmark suggests that type 2 diabetes may be associated with a reduced risk for the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS), according to an article published online by JAMA Neurology.
Recent reports have suggested a protective association between vascular risk factors, such as obesity or higher body mass index (BMI), higher cholesterol levels and hyperlipidemia with ALS incidence and survival. Patients with type 2 diabetes have, on average, higher BMI, elevated blood lipid levels and defective energy metabolism. However, ...
